The origins of antimalarial drug resistance

Trends in Parasitology

Volumn 20, Issue 11, 2004, Pages 512-518

  Hastings, Ian M ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; PYRIMETHAMINE; SULFADOXINE;

ANTIMALARIAL ACTIVITY; HOST PARASITE INTERACTION; HUMAN; IMMUNE SYSTEM; MALARIA; MICROBIAL GENETICS; MOLECULAR BIOLOGY; MOLECULAR EVOLUTION; MUTAGENESIS; NONHUMAN; PARASITE VIRULENCE; PLASMODIUM FALCIPARUM; REVIEW;

PLASMODIUM FALCIPARUM;

EID: 4744343699     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2004.08.006     Document Type: Article

References (43)

1. K. Marsh Malaria disaster in Africa Lancet 352 1998 924 925
2. J.F. Trape Impact of chloroquine resistance on malaria mortality C.R. Acad. Sci. III 321 1998 689 697
3. C.A. Goodman Cost-effectiveness of malaria control in sub-Saharan Africa Lancet 354 1999 378 385
4. I.M. Hastings, and U. D'Alessandro Modelling a predictable disaster: The rise and spread of drug-resistant malaria Parasitol. Today 16 2000 340 347
5. N.J. White Antimalarial drug resistance and combination chemotherapy Philos. Trans. R. Soc. Lond. B Biol. Sci. 354 1999 739 749
6. J.C. Wootton Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum Nature 418 2002 320 323
7. I.M. Hastings Modelling parasite drug resistance: lessons for management and control strategies Trop. Med. Int. Health 6 2001 883 890
8. J.F. Cortese Origin and dissemination of Plasmodium falciparum drug- resistance mutations in South America J. Infect. Dis. 186 2002 999 1006
9. S. Nair A selective sweep driven by pyrimethamine treatment in SE Asian malaria parasites Mol. Biol. Evol. 20 2003 1526 1536
10. C. Roper Antifolate antimalarial resistance in southeast Africa: a population-based analysis Lancet 361 2003 1174 1181
11. T.E. Wellems, and C.V. Plowe Chloroquine-resistant malaria J. Infect. Dis. 184 2001 770 776
12. I.M. Hastings A requiem for chloroquine Science 298 2002 74 75
13. I.M. Hastings Malaria control and the evolution of drug resistance: an intriguing link Trends Parasitol. 19 2003 70 73
14. R.M. Anderson, and R.M. May Infectious Diseases of Humans 1992 Oxford University Press
15. H.D. Crofton A model for host-parasite relationships Parasitology 63 1971 343 364
16. J.L. Hii Spatial and temporal variation in abundance of Anopheles (Diptera: Culicidae) in a malaria endemic area in Papua New Guinea J. Med. Entomol. 34 1997 193 205
17. T. Smith Mapping the densities of malaria vectors within a single village Acta Trop. 59 1995 1 18
18. M.E.J. Woolhouse Heterogeneities in the transmission of infectious agents: Implications for the design of control programs Proc. Natl. Acad. Sci. U. S. A. 94 1997 338 342
19. C. Dye, and G. Hasibeder Population dynamics of mosquito-borne disease: effects of flies which bite some people more frequently than others Trans. R. Soc. Trop. Med. Hyg. 80 1986 69 77
20. W. Takken, and B.G.J. Knols Odor-mediated behavior of Afrotropical malaria mosquitoes Annu. Rev. Entomol. 44 1999 131 157
21. I.M. Hastings, and M.J. Mackinnon The emergence of drug-resistant malaria Parasitology 117 1998 411 417
22. J.F. Crow, and M. Kimura An Introduction to Population Genetics Theory 1970 Harper & Row
23. D.L. Hartl, and A.G. Clark Principles of Population Genetics 1997 Sinauer Associates
24. N.J. White, and W. Pongtavornpinyo The de novo selection of drug-resistant malaria parasites Proc. R. Soc. Lond. B. Biol. Sci. 270 2003 545 554
25. I.M. Hastings The evolution of drug resistant malaria; the role of drug elimination half-life Philos. Trans. R. Soc. Lond. B Biol. Sci. 357 2002 505 519
26. W. Sirawaraporn Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase Proc. Natl. Acad. Sci. U. S. A. 94 1997 1124 1129
27. N.J. White The assessment of antimalarial drug efficacy Trends Parasitol. 18 2002 458 464
28. A. Djimde A molecular marker for chloroquine-resistant falciparum malaria N. Engl. J. Med. 344 2001 257 263
29. A.M. Nzila Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethamine/sulfadoxine compared with the shorter acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum J. Infect. Dis. 181 2000 2023 2028
30. W.M. Watkins The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses Parasitol. Today 13 1997 459 464
31. M.D. Hastings Highly pyrimethamine-resistant alleles of dihydrofolate reductase in isolates of Plasmodium falciparum from Tanzania Trans. R. Soc. Trop. Med. Hyg. 96 2002 674 676
32. A.G. Craig, and A. Schert Molecules on the surface of the Plasmodium falciparum infected erythrocyte and their role in malaria pathogenesis and immune evasion Mol. Biochem. Parasitol. 115 2001 129 143
33. L. Molineaux Plasmodium falciparum parasitaemia described by a new mathematical model Parasitology 122 2001 379 391
34. S. Paget-McNicol The Plasmodium falciparum var gene switching rate, switching mechanism and patterns of parasite recrudescence described by mathematical modelling Parasitology 124 2002 225 235
35. M.L. Gatton Time of treatment influences the appearance of drug-resistant parasites in Plasmodium falciparum infections Parasitology 123 2001 537 546
36. S. Paget-McNicol, and A. Saul Mutation rates in the dihydrofolate reductase gene of Plasmodium falciparum Parasitology 122 2001 497 505
37. W. Peters Chemotherapy and Drug Resistance in Malaria 1987 Academic Press
38. World Health Organisation Antimalarial Drug Combination Therapy. Report of a Technical Consultation 2001 World Health Organisation
39. C.V. Plowe Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine- sulfadoxine use and resistance J. Infect. Dis. 176 1997 1590 1596
40. C.H. Sibley Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol. 17 2001 582 588
41. W.M. Watkins, and M. Mosobo Treatment of Plasmodium falciparum malaria with pyrimethamine-sulphadoxine: selective pressure for resistance is a function of long half-life Trans. R. Soc. Trop. Med. Hyg. 87 1993 75 78
42. S. Looareesuwan Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand Am. J. Trop. Med. Hyg. 54 1996 62 66
43. O. Diekmann, and J.A.P. Heesterbeek Mathematical Epidemiology of Infectious Diseases: Model Building, Analysis and Interpretation 2000 Wiley and Sons